Fig. 6From: Erythropoiesis stimulating agents and reno-protection: a meta-analysisESAs in anemic CKD patients. The 18 trials were divided into 2 groups. In 6 trials there was no ESAs administered in the control group. In 12 trials some patients in the control groups were given ESAs. The RR and range for each group (filled diamonds) and the overall RR (open diamond) are shownBack to article page